Impaired regeneration of the peripheral B cell repertoire from bone marrow following lymphopenia in old mice.

Archive ouverte

Li, Fang | Jin, F. | Freitas, Antonio | Szabo, Paul | Weksler, Marc E.

Edité par CCSD ; Wiley-VCH Verlag -

International audience. Aging is associated with a decreased production of B cells by the bone marrow and an increased life-span of peripheral B cells. To determine whether the decreased bone marrow B cell production is linked to the increased life-span of B cells in old mice, B cell regeneration following lymphopenia was studied in young and old mice. The rate of bone marrow pre-B cell and of splenic B cell regeneration is slower in irradiated, old compared to irradiated, young recipients of young, congeneic bone marrow. This finding reflects an age-associated defect in the bone marrow microenvironment. As the bone marrow is the only source of a diverse population of B cells, we measured the diversity of the splenic B cell repertoire regenerated following drug-induced lymphopenia in old and young mice. The heterogeneity of mRNA size from IgH complementarity determining region 3 (CDR3) was more restricted in splenic B cells from old compared to young mice providing additional evidence for an age-associated impairment in B cell production by the bone marrow.

Consulter en ligne

Suggestions

Du même auteur

Reduced EBF expression underlies loss of B cell potential of hematopoietic progenitors with age.

Archive ouverte | Lescale, Chloé | CCSD

International audience. Summary Aging is accompanied by a reduction in the generation of B lymphocytes leading to impaired immune responses. In this study we have investigated whether the decline in B lymphopoiesis ...

Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study.

Archive ouverte | Shapira-Frommer, R. | CCSD

International audience. ObjectiveTreatment options for advanced vulvar cancer are limited. We evaluated pembrolizumab monotherapy in patients with advanced vulvar squamous cell carcinoma (SCC) enrolled in the phase ...

Pembrolizumab in Microsatellite Instability High or Mismatch Repair Deficient Cancers: Updated Analysis from the Phase 2 KEYNOTE-158 Study.

Archive ouverte | Maio, M. | CCSD

International audience. BackgroundPembrolizumab demonstrated durable antitumor activity in 233 patients with previously treated advanced microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) ad...

Chargement des enrichissements...